Skip to Content

INVESTABLE HEALTH INVESTABLE WORLD

Aging populations and emerging health threats are straining healthcare delivery and adding to pressure on costs. Investors are using data to help increase access to healthcare and uncover emerging opportunities.

Explore the Data

Improving Access to Vaccines

COVID-19 has shown that global vaccination is required to combat pandemics. Yet vaccination rates in low-income countries are far lower than in rich countries. Activists are targeting drug industry policies, with mixed success.

Understanding the ESG Risks in
Drug Pricing

Americans pay twice as much for their drugs as patients in most developed countries. Insurers, employers, and voters want to rein in costs. How can investors manage the risk that the price of drugs may not always reflect their effectiveness.

The Opportunities of
Digital Health

The consumerization of healthcare is accelerating, bringing digital technologies to care delivery, diagnostics, and wellness. Investors seeking opportunities in emerging health technology can find them in the venture capital market.

Research & Data

Explore our data visualization tool to assess risk, performance, and impact across a global landscape of health funds.

Explore the Data

Learn more

Read more about Morningstar’s ESG Solutions or dig deeper into our sustainable investing research and insights.

Go to ESG Solutions Page

Go to ESG Research Hub

Transparency is our policy. Learn how it impacts everything we do.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.